Basit öğe kaydını göster

Serum interleukin 1 alpha and interleukin 2 levels in patients with schizophrenia

dc.contributor.authorOncul, O
dc.contributor.authorCetin, M
dc.contributor.authorTop, C
dc.contributor.authorBasoglu, C
dc.contributor.authorCavuslu, S
dc.contributor.authorEbrinc, S
dc.date.accessioned2021-03-06T12:09:33Z
dc.date.available2021-03-06T12:09:33Z
dc.date.issued2002
dc.identifier.citationEbrinc S., Top C., Oncul O., Basoglu C., Cavuslu S., Cetin M., "Serum interleukin 1 alpha and interleukin 2 levels in patients with schizophrenia", JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, cilt.30, ss.314-317, 2002
dc.identifier.issn0300-0605
dc.identifier.othervv_1032021
dc.identifier.otherav_f283d69c-658e-4bce-9433-251b93ba0b98
dc.identifier.urihttp://hdl.handle.net/20.500.12627/159064
dc.identifier.urihttps://doi.org/10.1177/147323000203000313
dc.description.abstractIt has been suggested that altered interleukin (IL) regulation may be involved in the pathogenesis of schizophrenia. In this cross-sectional, case-controlled study, patients with schizophrenia and a control group of healthy subjects, matched by age, sex and body mass index, were evaluated. The levels of IL-1alpha and IL-2 in blood serum were measured by enzyme-linked immunosorbent assay. The fasting serum IL-2 levels were significantly higher in patients with schizophrenia compared with the control subjects, but there was no difference between the fasting serum levels of IL-1alpha in patients with schizophrenia and the control subjects. Our results suggest that patients with schizophrenia have altered IL-2, but not IL-1alpha, regulation.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectYaşam Bilimleri (LIFE)
dc.titleSerum interleukin 1 alpha and interleukin 2 levels in patients with schizophrenia
dc.typeMakale
dc.relation.journalJOURNAL OF INTERNATIONAL MEDICAL RESEARCH
dc.contributor.department, ,
dc.identifier.volume30
dc.identifier.issue3
dc.identifier.startpage314
dc.identifier.endpage317
dc.contributor.firstauthorID2209581


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster